Tag Archives: QuADD

POLARISqb Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design
The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a research contract in support of their work designing drugs with quantum computers. The contract is a part of the Advanced Research Concept topic Imagining Practical Applications for a Quantum Tomorrow (IMPAQT). POLARISqb has been developing quantum computing methods for drug discovery since their inception in…
Read more
POLARISqb and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service
POLARISqb, the first company in the world to develop a drug discovery engine that utilizes the optimization power of quantum computing, announced that it has signed an MOU with Syntekabio (KOSDAQ: 226330), an Artificial Intelligence (AI) based drug development company. The partnership, which will combine the companies’ vanguard drug research platforms, will provide a collaborative…
Read more
POLARISqb Announces Quantum SaaS: Quantum Aided Drug Design (QuADD)
POLARISqb, an industry leader in accelerating drug discovery using quantum computing, is excited to announce Quantum-Aided Drug Design (QuADD). QuADD is a subscription-based SaaS platform that quickly identifies a library of top candidate molecules for drug targets. In order to find a new preclinical lead, the first step is to build a library of small…
Read more